The Challenge Awards will fund investigations of MedTech innovations in healthcare settings. The aim is to shorten the evidence gap between the safety/efficacy typical of a newly or nearly CE-marked technology and what is required for decisions by commissioners and regulators. At the same time, this will de-risk the product for follow-on investment.
Please note that nearly CE-marked technologies refers to technologies that are currently under Notified Body assessment, whereby all of the mandatory testing has been completed.
Competition Closes: 12 January 2022, 13:00
Slingshot